Abiopharma

🔍 Kelley Shannon T (Executive)

Company: MADRIGAL PHARMACEUTICALS, INC. (MDGL)

Reported stock transactions:

• Sold 458 shares of Common Stock at $358.66 per share (directly)
  Date: 2025-08-18 | Code: S
• Sold 126 shares of Common Stock at $369.64 per share (directly)
  Date: 2025-08-18 | Code: S
• Sold 84 shares of Common Stock at $370.06 per share (directly)
  Date: 2025-08-18 | Code: S
• Sold 84 shares of Common Stock at $371.35 per share (directly)
  Date: 2025-08-18 | Code: S
• Sold 252 shares of Common Stock at $372.44 per share (directly)
  Date: 2025-08-18 | Code: S
• Sold 68 shares of Common Stock at $374.13 per share (directly)
  Date: 2025-08-18 | Code: S
• Sold 190 shares of Common Stock at $375.75 per share (directly)
  Date: 2025-08-18 | Code: S
• Sold 42 shares of Common Stock at $376.62 per share (directly)
  Date: 2025-08-18 | Code: S